These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15536693)

  • 1. Uncomplicated pregnancy and birth of a normal child in thyroid cancer after high-dose 68 Gbq iodine 131.
    Massoudi-Nickel S; Kampen WU; Henze E; Knapp WH; Hornik S
    Nuklearmedizin; 2004 Oct; 43(5):N68-70. PubMed ID: 15536693
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy outcome after 131I therapy.
    Sioka C; Fotopoulos A
    J Nucl Med; 2009 Feb; 50(2):327; author reply 327-8. PubMed ID: 19164224
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer.
    Sioka C; Fotopoulos A
    Fertil Steril; 2011 Apr; 95(5):1552-9. PubMed ID: 21300333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
    Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pregnancy in women with thyroid carcinoma.
    Schlumberger M; De Vathaire F; Ceccarelli C; Francese C; Pinchera A; Parmentier C
    J Endocrinol Invest; 1995 Feb; 18(2):150-1. PubMed ID: 7629385
    [No Abstract]   [Full Text] [Related]  

  • 6. Consequences of inadvertent radioiodine treatment of Graves' disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing?
    Berg G; Jacobsson L; Nyström E; Gleisner KS; Tennvall J
    Acta Oncol; 2008; 47(1):145-9. PubMed ID: 17851865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer.
    Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
    J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    Tuttle RM; Leboeuf R; Robbins RJ; Qualey R; Pentlow K; Larson SM; Chan CY
    J Nucl Med; 2006 Oct; 47(10):1587-91. PubMed ID: 17015892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.
    Balenović A; Vlasić M; Sonicki Z; Bodor D; Kusić Z
    Coll Antropol; 2006 Dec; 30(4):743-8. PubMed ID: 17243543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
    Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
    Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
    [No Abstract]   [Full Text] [Related]  

  • 12. The usual dose of I-13U used to ablate thyroid.
    Caplan RH; Dvorak D
    J Nucl Med; 1977 Sep; 18(9):946. PubMed ID: 893800
    [No Abstract]   [Full Text] [Related]  

  • 13. [Care of thyroid carcinoma in pregnancy: Thyroglobulin content].
    Staudt J; Happel C; Middendorp M; Grünwald F
    Nuklearmedizin; 2010; 49(5):N38-40. PubMed ID: 20931151
    [No Abstract]   [Full Text] [Related]  

  • 14. Conception after iodine-131 therapy for differentiated thyroid cancer.
    Ayala C; Navarro E; Rodríguez JR; Silva H; Venegas E; Astorga R
    Thyroid; 1998 Nov; 8(11):1009-11. PubMed ID: 9848714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 16. How safe for the patient is iodine-131 therapy for differentiated thyroid carcinoma?
    Haynie TP; Vassilopoulou-Sellin R
    J Nucl Med; 1995 Jan; 36(1):27-8. PubMed ID: 7799077
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioiodine therapy and pregnancy.
    Watson WS; Balon HR; Meier DA; Silberstein EB
    J Nucl Med; 2005 Aug; 46(8):1408-9; author reply 1409. PubMed ID: 16085602
    [No Abstract]   [Full Text] [Related]  

  • 18. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk assessment after iodine-131 exposure: an opportunity and obligation for nuclear medicine.
    Dottorini ME
    J Nucl Med; 1996 Apr; 37(4):612-5. PubMed ID: 8691250
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
    Pahlka RB; Sonnad JR
    Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.